Quick Facts
FONT-SIZE Plus   Neg
Share SHARE

Wilmington Group Names Pedro Ros CEO - Quick Facts

Wilmington Group Plc. (WIL.L) said Pedro Ros would join the Board of Wilmington on July 14 and would assume the role of Group Chief Executive on October 1, following the publication of the Group's preliminary 2014 results and completion of the associated investor roadshow.

This follows the announcement of Charles Brady's retirement made on February 25.

Ros, 52, was until June 2012 CEO and then Chairman of TNS, a global subsidiary of advertising giant WPP Plc.

From January 2006 until the acquisition of TNS by WPP in October 2008, Ros was executive director of Taylor Nelson Sofres plc, and Managing Director, TNS Global Clients & Sectors.

Ros is Head of Strategic Insight at Creston plc, the digitally focused insight and communications group, a role which he will relinquish on June 13.

Click here to receive FREE breaking news email alerts for Wilmington Group and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
After moving sharply lower in early trading on Wednesday, stocks have seen continued weakness over the course of the trading session. Will the pullback, the major averages are adding to the modest losses posted in the two previous sessions. With spending on private and public construction both showing notable decreases, the Commerce Department released a report on Wednesday showing an unexpected drop in U.S. construction spending in the month of August. Growth in U.S. manufacturing activity saw a notable slowdown in the month of September, according to a report released by the Institute for Supply Management on Wednesday, with the index of activity in the sector pulling back off a three-year high.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.